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ABSTRACT
MIGRATION OF MURINE SUBVENTRICULAR ZONE ISOLATED
NEUROSPHERES
By
Danny Christopher LeBert

The subventricular zone (SVZ) of the adult brain is a region known to contain a
higher concentration of progenitor/stem cells than surrounding tissue. The SVZ
progenitor/stem cells can be isolated and purified using neurosphere culturing technique.
Neurosphere culturing is an attractive research model in that the lack of serum in culture
media keeps progenitor/stem cells from differentiating and has even been shown to
maintain genotypic and phenotypic profiles. The migratory capabilities of cancer cells
has been explored in detail to elucidate the mechanisms behind recurrence and
metastasis. However, the investigation of stem cells’ role in recurrence and metastasis has
only recently become an area of research. The current study examined the ability of
neurospheres to migrate towards glioblastoma (GBM) cells and investigated the
interaction of neurospheres with GBM released exosomes as a possible means to
subsequent transformation into cancer stem cells (CSCs). Migration assays indicated
that neurosphere isolates from the murine SVZ did not migrate toward GBM cells but
were repelled in vitro. Interestingly, neurospheres are also repelled by serum containing
media. These findings refute multiple studies that have indicated a chemo-attractive
governance of stem cell migration by GBMs.
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CHAPTER ONE: LITERATURE REVIEW AND BACKGROUND

INTRODUCTION:
The central nervous system (CNS) is composed of several cell types, the most
numerous of which are glia and neurons. Glia is further subdivided into astrocytes,
microglia and oligodendrocytes. Under normal physiological conditions, glia typically
acts as scaffolding upon which neurons build networks and interact. Mutation in glial
cells can result in a phenotypic change from a structural role to one characterized by
rapid proliferation and invasiveness. (Markert)
Cancer is a class of disease characterized by uncontrolled cell growth, tissue
invasiveness and metastasis (Reya et al.). Even after diagnosis and treatment with
radiation and chemotherapeutic agents, many cancers prove to be resilient. According to
the American Cancer Society, cancers caused approximately 7.6 million deaths in 2007,
and the number continues to rise annually. Gliomas result from cancerous processes
which induce histological and morphological changes in astrocytes and oligodendrocytes
(Markert). The most malignant form of glioma is the grade IV glioblastoma multiforme
(GBM) (Vescovi, Galli and Reynolds). Derived from astrocytic precursor cells, grade IV
GBMs have a poor patient prognosis.
Gliomas account for 42% of all primary CNS tumors and 77% of all malignant
primary CNS tumors (CBTRUS, 2005). Historically, treatment of malignant gliomas has
included resection followed by radiotherapy. This form of treatment has achieved a mean
survival time of only nine months (Ashby and Ryken). From 1969 to 1991, the
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introduction of new chemotherapy agents such as carmustine, lomustine and nimustine
(nitrosureas) increased the one year survival rate from 40% to 46% when used
concomitantly with radiotherapy (Stewart). The mean survival rate also rose during this
time to nearly 12 months. Initially introduced in 1996, temozolomide (TMZ) and the
gliadel wafer gained notoriety in 2005 when the New England Journal of Medicine
published two papers indicating concomitant use with radiotherapy increased the mean
survival to 14.6 months (Hegi et al.; Stupp et al.). Since that time, these treatments have
been adopted as the standard of care for malignant glioma treatment. Despite the
improvements, current GBM treatment only slightly improve overall survival times, often
with the accompaniment of a decreased standard of living due to the treatments. The
mechanism for postoperative GBM recurrence remains elusive. Current evidence points
toward malignant cell migration into surrounding brain tissue as being the most
prominently accepted hypothesis for cancer dispersal (Ehtesham et al.). Surgical
resection removes the tumor; distal malignant cells however, are left behind. Subsequent
radio- and chemotherapy treatments keep the cells from proliferating initially, but also
“select” for cells resistant to the treatments (Holland). It is at this point that the GBM
recurs with treatment no longer effective.

BACKGROUND
The unfavorable GBM prognosis is due in part to postoperative tumor recurrence.
Studies have shown that recurrence is inevitable for any individual surviving longer than
32-36 weeks (Ammirati et al.). GBM recurrence shows varied presentation of new
2

lesions which has led to an ambiguous definition. Most commonly, GBM recurrence is
defined as a change in tumor growth compared to a previous interval of tumor absence or
a loss of prior complete tumor control (Barker et al.).
When reviewing models explaining possible GBM recurrence patterns, it is
important to address the processes underlying tumor formation. There are two cancer
stem cell related explanations for the initiation of tumor growth: The first hypothesis
describes the de-differentiation of cancer cells into cancer stem cells (CSC). The second
hypothesis describes the mutation of a stem cell (SC) into a CSC (Civenni and Sommer;
Yang and Weinberg). Both hypotheses suggest that tumor progression is due to a
subpopulation of tumor cells with stem cell like properties.
Stem cells are not easily identified morphologically or phenotypically, though
they are more commonly defined by functional criteria. First, the cells in question must
be capable of self-renewal. Second, they must be able to differentiate into all mature cell
types. Lastly, the cells must be capable of repopulating in vivo (Louis et al.). In 2004, a
study by Shiela Singh et al., identified CD133+ (cluster of differentiation 133), brain
tumor cells as having stem cell like properties in vitro. They proposed CD133 as a stem
cell marker, and according to their study, the CD133+ cell populations were the only cells
capable of initiating tumors in non-obese diabetic, severe combined immuno-deficient
(NOD-SKID) mice (Singh et al.). In recent years CD133 marker has failed to achieve
widespread acceptance as an accurate stem cell marker. However the presence of a CSC
subpopulation within tumor masses is widely accepted. The growth potential of a tumor
appears to be governed by the CSC subpopulation found within its mass. The question
3

remains whether accumulation of mutations within a cancer cell allows for dedifferentiation into a CSC and subsequent tumor formation, or if tumor formation is the
result of the cancerous transformation of a stem cell.
The de-differentiation hypothesis is supported by evidence of epithelialmesenchymal transition (EMT). The process of EMT causes epithelial cells to convert to
a less differentiated form allowing them to lose rigid structural constraints, adopt a
phenotype more permissive to migration with greater proliferative capabilities (Yang and
Weinberg). This process has been definitively linked to neurofibroma formation (Joseph
et al.). Neurofibromas are benign nerve sheath tumors found in the peripheral nervous
system. Though compelling, there is not enough evidence to confirm that all tumors are
caused via this pathway or similar processes. This lack of evidence supports the theory
that CSCs arise simply through the mutation of a normal SC. Regardless of the steps
leading to their formation, CSCs appear necessary for the formation of a tumor mass. It
seems plausible that CSCs may also be responsible for tumor recurrence.
Currently, the accepted model for recurrence is as follows: A cell becomes
transformed into a CSC through the mutation of a SC or de-differentiation of a cancer
cell. The CSC posses SC capabilities and are able to proliferate indefinitely to form a
tumor. Within the tumor, a sub-population of CSCs accumulates. Over time the CSCs
migrate away from the main tumor mass forming satellite cancer sites. Upon tumor
resection, the satellite cells remain undetected. If residing in a favorable microenvironment, the CSCs will begin to proliferate and the tumor recurs (Civenni and
Sommer).
4

NEURAL STEM CELLS AND NEUROSPHERES
Embryonic stem cells (ESC) were initially characterized independently by two
groups in 1981. Martin Evans and Matthew Kaufman at the University of Cambridge
first published a technique for culturing mouse ESCs (Evans and Kaufman). It was not
until later that year that Gail R. Martin at the University of California coined the term
embryonic stem cell after successfully culturing cells taken from mouse embryos
(Martin). Since that time, research has led to the thorough characterization of stem cells
and the elucidation of a cellular hierarchy (Ratajczak et al.).
At the top of the hierarchy are totipotent cells that arise during the morula stage of
embryonic development. These cells are capable of giving rise to an entire organism,
including the extra embryonic tissues required for development. During embryonic
development, the cells of the morula begin differentiating after reaching the 16 cell stage
(Wilbur). The cells, at this point in development, are considered pluripotent. Including
ESCs, the cells at this stage can produce all three germ layers (endoderm, ectoderm and
mesoderm), but cannot form the extra embryonic tissues. Below the pluripotent cells in
the hierarchy are the multipotent SCs, which include NSCs. These cells can differentiate
into multiple cell types and are typically tissue specific.
In 1992 adult NSCs were discovered in mice (Reynolds and Weiss). However, the
concept of adult NSCs weren’t fully accepted until 2001. It has since been shown that
the largest neurogenic region in the adult brain is the subventricular zone (SVZ) (Okano
and Sawamoto). Within the SVZ are three cell types: Types B, C and A (Doetsch, GarciaVerdugo and Alvarez-Buylla). Type B cells divide slowly and have been shown to act as
5

stem cells (Doetsch et al.). These stem cells produce highly proliferative transitamplifying or progenitor cells. Progenitor cells are Type C cells. Type C cells generate
Type A cells, which are neuroblasts capable of migration as well as differentiation into
nerves or glia (Doetsch, Garcia-Verdugo and Alvarez-Buylla).
Stimulation of the SVZ cell types through the addition of growth/neurotrophic
factors causes a significant increase in cellular proliferation and migration. Infusion of
exogenous epidermal growth factor (EGF) directly into the SVZ has been shown to
induce both the migration of cells into the striatum and subsequent differentiation into
glia (Craig et al.; Kuhn et al.). Additionally, using SVZ-specific labeling, evidence has
indicated the directed migration of SVZ cells towards an area of trauma. In a study by
Yamashita et al., middle cerebral artery occlusion (MCAO) was induced to cause
ischemia at the striatum. The labeled SVZ cells were tracked and shown to migrate
preferentially towards the site of the ischemia (Yamashita et al.). The findings indicate
migration was promoted either through ischemia induced disruption of SVZ sequestering
or through an alteration of local chemokine expression.
Isolates from the SVZ are commonly cultured as neurospheres. Since the
majority of cells isolated from the SVZ are not SCs, neurosphere culture conditions were
adopted to aide in the purification of the isolate. The culture media is such that it allows
progenitor cells to proliferate without having contact to the culture flask. The result is an
overall selection for progenitor (PC) and SCs as these are the cells types capable of
contact independent proliferation under the culture conditions (Laks et al.). Once the PCs
and SCs begin to proliferate, they form floating clusters of cells known as neurospheres.
6

At the center of each individual neurosphere is a single PC or SC. The neurospheres are
mechanically dissociated at each subsequent passage resulting in an overall increase in
PC quantity. The process can be continued indefinitely while keeping the genotypic and
phenotypic profile of the cells from changing (Fedoroff et al.). The result is cells that are
genotypically identical at passage one and passage 20 with the same ability to
differentiate into all of the proper cell types.
The neurosphere assay has become the gold standard for the culturing of primary
brain tumors. Cancer cells lack anchorage dependence for proliferation thus making the
neurosphere culture system a viable growth system. The neurosphere method is also
beneficial in that it allows for a much “cleaner” growth flask meaning that non-cancerous
cells are quickly separated from the cells capable of proliferating. Once in culture, the
GBM cells respond similarly to the SCs in that CSCs begin forming neurospheres. Like
the SCs, the GBM-neurospheres maintain their genetic fingerprint with each subsequent
passage. This property allows for in vitro testing on cells that are identical to the original
tumor sample.
The key to maintaining cellular profiles is linked to the lack of serum within the
culture media (Laks et al.). Multiple studies on GBM-neurospheres have supported this
finding. Using the GBM-neurosphere method to implant tumors into mice has yielded
tumor masses that grow quicker and are more invasive than GBM implants grown with
serum (deCarvalho et al.). The neurosphere-induced tumors can be re-isolated and once
more cultured using the neurosphere method. The neurospheres formed post-xenograft
have been shown to be genetically identical to the cells originally taken from the human
7

primary brain tumor. The same neurospheres can then be transferred to and cultured in
serum-containing media. Within two passages, the cells’ genotypic and phenotypic
profiles no longer match the original tumor (deCarvalho et al.).

CELL MIGRATION
Cellular migration occurs due to an interaction of secreted factors and surface
receptors. The secreted factors include growth factors and chemokines that act as ligands
(Ehtesham et al.). These ligands include, but are not limited to neuregulin-1 (Ritch,
Carroll and Sontheimer), ephrin-B1 (Nakada et al.), and stromal cell-derived factor-1
alpha (SDF-1α) (Tiveron and Cremer). When separated from chemo-attractants in the
form of a concentration gradient, cells will display polarity in their movement towards
the desired ligand (Suzuki and Iwaki). This indicates that cells intrinsically migrate, nonrandomly, towards specific signals.
Previous findings have shown that SDF-1α interacts with the surface receptor
CXCR4 to strongly promote cell migration (Ehtesham et al.). The interaction of SDF1-α
and CXCR4 is unique in its specificity (Burns et al.). The majority of ligands bind to
multiple receptors, however, SDF-1α has only been found to bind to two, CXCR4 and
CXCR7. The interaction between CXCR7 and SDF1-α plays an important role in tumor
growth and survival, but no link has yet been made with migration (Burns et al.).
SDF-1 has three isoforms: SDF-1α, SDF-1β and SDF-1γ. SDF-1α and β proteins
are encoded by a single gene at chromosome 10q and are generated by alternative
8

splicing (Shirozu et al.). SDF-1α has an additional 4 amino acids at the C-terminal end to
total 89 amino acids. Sequence analysis shows that SDF-1α is highly conserved between
species, 92% identical between murine and human according to Entrez-Gene. It is also
ubiquitously expressed throughout the body (Shirozu et al.). The third isoform, SDF-1γ,
is only expressed in neurons and Schwann cells.
SDF-1 gene expression is regulated by the transcription factor hypoxia-inducible
factor-1 (HIF-1) (Shirozu et al.). HIF-1 is only stable under hypoxic (low oxygen)
conditions. HIF-1 binds to HIF-responsive elements (HREs) to promote the expression
of glycolysis enzymes, SDF1-α, and vascular endothelial growth factor (VEGF)
(Ceradini et al.). These genes promote cell survival and induce angiogenesis. For tumors
to grow, they must overcome hypoxic conditions and promote angiogenesis in order to
keep nutrients available for the expanding cell population. Endothelial progenitor cells
(EPCs) and hematopoietic stem cells (HSCs) are important for these processes. These
cells are capable of self-renewal and trans-differentiation (creation of cells outside of a
designated differentiation path) and their motility is governed by SDF1-α – CXCR4
interactions (Weidt et al.). Taken together, it is not surprising that SDF-1α
concentrations are abnormally high in glioblastoma tissue (Imitola et al.).
CXCR4 is a 7-transmembrane G protein-coupled receptor expressed in a variety
of tissues including the brain and in many cell types (Weidt et al.). Knockout experiments
indicate that CXCR4 is involved in several physiological processes. For instance,
CXCR4 deficiency experiments in mice yield hematopoietic and cardiac defects (Zou et
al.). Another study indicates that CXCR4 is also necessary for vascularization of the
9

gastrointestinal tract (Tachibana et al.). Subsequent studies using SDF-1α deficient mice
found the same lack of vascularization, thus highlighting the importance of the CXCR4 –
SDF-1α interaction (Weidt et al.).
The migration of neural stem cells has also been linked to the CXCR4 – SDF-1α
interaction. In both the developing and adult brain, CXCR4 and SDF-1α show a
complementary expression pattern (Tiveron and Cremer). Ehtesam et al., (2008) were
able to demonstrate that NSCs migrate toward tumor conditioned media in vitro.
Migratory capabilities were then neutralized by inhibiting SDF-1α with an antibody
(Ehtesham et al.). Another study, by Imitola et al., (2004) used pre-labeled human NSCs
and transplanted them into stroke patients. They were able to track the movement of the
NSCs and found their movement was polar in nature towards the sites of damage. These
sites were then characterized and found to contain elevated levels of SDF-1α (Imitola et
al.).
Neural stem cells interact with many chemotactic ligands, the result of which is
guidance towards a specific location. However, not all ligands act in a chemo-attractive
manner. For instance, under normal physiological conditions, NSCs remain sequestered
in the SVZ in a quiescence state due to a chemo-repellent interaction with the Slit family
of proteins (Wu et al.). Also an important class of CNS chemo-repellents are the
semaphorins. The semaphorins consist of more than 20 secreted and membrane bound
proteins important for the regulation of axonal guidance (Goshima, Ito et al.). The
semaphorins are divided into 8 separate categories based on their domain organization as
well as the species in which they are found. A common domain shared by each of the
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family members is the presence of a 500 amino acid “Sema” signature found at the amino
terminal (Rieger, Wick and Weller). Characterized under the class 3 semaphorins,
Sema3A has been shown to be a strong chemo-repellent that effects axonal outgrowth
(Goshima, Sasaki et al.). Sema3A is a secreted semaphorin that binds with high affinity
to the neuropilin-1 (Nrp-1 receptor).
The neuropilins are a group of 2 transmembrane glycoproteins and are receptors
for the class 3 semaphorins. As mentioned previously, Sema3A binds with high affinity
to Nrp-1. The other two class 3 semaphorins, Sema3C and Sema3F, bind to both Nrp-1
and Nrp-2 (Nakamura, Kalb and Strittmatter). The neuropilins have extremely short
cytoplasmic tails and rely on other proteins, such as the plexins, for signal transduction
(Tamagnone et al.). The only other known binding partner for Nrp-1 is the vascular
endothelial growth factor isoform VEGF165. As a co-receptor, the Nrp-1 interaction
increases the binding affinity of VEGF165 with the kinase insert domain receptor (KDR),
a receptor tyrosine kinase (Goshima, Ito et al.). The presence of Nrp-1 is required for the
interaction of VEGF165 and KDR (Miao et al.). The VEGF165 – KDR interaction is
important for cancer cell survival and proliferation (Goshima, Ito et al.). Interestingly,
Sema3A and VEGF165 compete for the Nrp-1 binding site and have opposing effects on
overall cell motility.
The Sema3A – Nrp-1 signal cascade has yet to be fully characterized. What is
known is the first step involves the lipid raft-dependent endocytosis of Nrp-1 upon
binding to Sema3A (Salikhova et al.). The specific mechanisms underlying this process
remain largely unknown. Upon localization to the cytoplasm, Nrp-1 interacts with
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synectin. Synectin (also commonly known as GIPC) is a postsynaptic density 95, disk
large, zona occludens-1 (PDZ) adaptor protein. Synectin is required for the coupling of
the Nrp-1 containing lipid raft to motor myosin VI (Naccache, Hasson and Horowitz).
The synectin – Nrp-1 interaction is required for developmental angiogenesis in zebra fish
as well as endothelial cell migration (Wang, Mukhopadhyay and Xu). Sema3A induces
cell migration through the activation of the Rac1 GTPase (Kolodkin et al.). Rac1
moderates the signaling cascade controlling F-actin dynamics, the end result yields
increased motility away from the source of Sema3A.
Historically, the role of chemokines in the brain was thought to be limited to
mediating normal neural development. Evidence of neurogenesis in the adult brain and
subsequent identification of adult neural stem cells led to a broadening of these roles with
a distinct link to cancer. As discussed previously, SDF1-α plays an important role in
promoting angiogenesis through the attraction of EPCs to a growing tumor mass. The
use of proteomic screens of GBM surface proteins demonstrated that another chemokine
was affecting GBM progression. The proteomic screen indicated Nrp-1 to be nearly
ubiquitously expressed in cells of the most malignant cases (Eustace et al.). A study of
12 malignant glioma cell lines showed Sema3A to be highly expressed indicating a
possible autocrine signaling pathway (Rieger, Wick and Weller). The result of such a
pathway could result in dispersal of malignant cells through the brain.
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EXOSOMES AND CELL TRANSFORMATIONS
Exosomes are membrane vesicles secreted by multiple cell types including tumor
cells (Keller et al.). An exosome is formed when an early endosome invaginates forming
an internal luminal vesicle (ILV). The ILV can go down either of two pathways,
lysosomal degradation or fusion with the plasma membrane and subsequent release as
exosomes (Johnstone). Exosomes have been found to vary greatly in their morphologic
features and content (Iero et al.). Once in the extracellular matrix, exosomes can be taken
up by neighboring cells through endocytosis (Johnstone).
Exosomal release begins with the initial invagination of vesicles at the limiting
membrane of the cell (Fevrier and Raposo). This invagination keeps proper orientation of
extracellular proteins, while cytosolic proteins are engulfed within the 50-90 nm ILVs.
The ILVs accumulate and form multivesicular bodies (MVBs) within the cell (Fevrier
and Raposo). At this stage, the exosome is considered to be each of the ILVs contained
within a single MVB. The whole process creates MVBs, and more specifically, ILVs
with a common set of molecules, but also with cell-type specific components. It is
therefore possible to determine the cellular origin of an exosome by looking at the
specific protein/mRNA components (van Niel et al.).
Analysis of exosome containing serum using Western-blotting and
immunocytochemistry is used to identify cellular origin of exosomes using proteomics.
These methods have identified the following exosomes based on cell-type specific
mRNAs; MHC classes I and II (antigen presenting cells), CD-3 (T cells), GluR2/3
(neurons) and EGFRvIII (cancer cells) (van Niel et al.; Al-Nedawi et al.). As mentioned
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before, exosomes contain common components including but not limited to: chaperone
protein mRNA (Hsc70 and Hsp90), sub-units of trimeric G-proteins, endosomal sorting
complex required for transport (ESCRT) proteins (TSG101) and proteins involved in
transport and fusion (Annexins, Rab2, Rab7) (van Niel et al.). Other studies have shown
that certain molecules such as caspase mRNAs are found in higher concentrations within
the exosomes than are found within the cell they originated from (Cocucci, Racchetti and
Meldolesi). This led to research investigating the specific molecular packaging into
exosomes.
Studies on protein sorting into ILVs indicate that mono-ubiquitination of targets
as well as ESCRT machinery may play a role in preferential sorting. The sorting begins
with target molecule mono-ubiquitination recognition by the endosomal-associated
protein, Hrs, which forms a complex with signal transducing adaptor molecules (STAM),
epidermal growth factor receptor substrate 15 (Eps15) and clathrin at the limiting
membrane. Tsg101 of ESCRTI is recruited to the complex, which in turn recruits
ESCRTII and ESCRTIII. The machinery is then broken down and recycled by Vps4 an
AAA–ATPase (Babst et al.). However, not every mRNA within the ILV is ubiquitinated
thus implying an alternative ESCRT – independent mechanism. An example is the
sorting of the pre-melanosomal protein (Pmel17) which has been observed within ILVs,
while lacking the ubiquitin tag (Theos et al.).
Once packaged and released from the host cell, exosomes can be taken-up by
other cells. This may enable cells to communicate or “cross-talk” with one another.
Communication by mRNA shuttling may provide cells a means of adapting to changes in
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their immediate environment. This process may also be important in cell survival. Such
is the case with complement activation of the membrane attack complex (MAC) in K562
erythroleukemia cells (Pilzer and Fishelson). Activation induces accumulation of MACs
within the cell until reaching lytic concentrations. However, these cells preferentially
sort MACs into ILVs and release them from the cell (Pilzer and Fishelson). Not all ILV
interactions end favorably for the cell. Macrophages have been observed receiving
CCR5 receptors from ILVs. This accumulation of CCR5, a co-receptor for the human
immune deficiency virus (HIV) induces an increased risk of disease progression for
individuals with the HIV infection (Mack et al.). Other studies have shown T
lymphocytes receiving the death receptor ligand, Fas, which in turn leads to increased
frequency of apoptosis (Kim et al.). Also affected by the release of ILVs is the immune
system.
The immune system is typically activated during initial tumor formation but
becomes blunted by tumor induced activation of suppressive pathways. Immunosupression ranges from dysfunctional dendritic cells to apoptosis of antitumor effector T
cells in cancer patients (Iero et al.). The exact mode of action has yet to be discovered
but a broad array of soluble factors and cell to cell contact mediated interactions have
been correlated with immune dysfunction. A model is beginning to take shape in which
tumor cells evade the immune system through the secretion of ILVs. The general idea is
that ILVs can present antigens which stimulate an immune response (Iero et al.). The
immune system essentially ignores the growing tumor body as it deals with the antigen
presenting ILVs. Immune-response eliciting ILV antigens include gp100, CEA and
HER2-Neu (Andre et al.).
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Evidence behind ILV-exosome release from tumor cells and their subsequent role
in cell survival and immune avoidance has been steadily growing. Exosomes can be
taken into cells and have their contents expressed such as the case discussed earlier in
which macrophages took in exosomes containing CCR5. It therefore seemed plausible
that cells could take in cancer released exosomes and express tumor-specific proteins. To
investigate this theory, tumor-released exosomes containing the oncogenic epidermal
growth factor receptor EGFRvIII were isolated from serum of tumor-bearing mice.
These exosomes were introduced to cells not expressing the oncogenic factor. The
exosomes were not only taken up by the cells, but the EGFRvIII was expressed. The
expression was then linked to the activation of MAPK and Akt pathways as well as
morphological transformation. (Al-Nedawi et al.)

PROJECT OBJECTIVES
Cell motility regulates tumor invasiveness and is an integral portion of all
recurrence and metastasis models. The interactions of the ligands SDF-1α with CXCR4
and Sema3A with Nrp-1 have a role in the cellular migrations observed in both the
developing and adult CNS. These ligand-receptor interactions are an interesting link in
tumor recurrence in that they are normal physiological cues. This project investigates an
alternative recurrence model. The model suggests that NSCs migrate towards a tumor
mass through the attractive interactions of SDF-1α and CXCR4. The NSCs interact with
an increasing gradient of exosomes as they near the tumor. These exosomes contain
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tumor-specific mRNA and may cause a subsequent transformation into a CSC. The end
result of this process would be the formation of a secondary or recurrent tumor.
The alternative recurrence model predicts that neurospheres will migrate in a
directed manner towards a tumor. To test, GBM-containing and GBM-conditioned
media was used in a transwell assay. Characterization of overall migration patterns was
achieved by comparison to the migration of neurospheres towards unmodified media.
Migration towards the unmodified media was considered intrinsic cellular motility and
set as a baseline. The results indicated that the hypothesized migration of neurospheres
towards tumor cells was not supported by the data. An overall repulsive effect upon the
neurospheres was observed, which led to an investigation of the exosomes contained
within the GBM-conditioned media. Migratory governance of exosome-free, GBMconditioned media was compared to GBM-conditioned media from which it was derived.
Finally, SDF-1α was added to GBM-conditioned media in hope of returning neurosphere
migration capabilities.
In order to support the alternative model, neurospheres must be shown to migrate
towards SDF-1α containing media. Neurosphere migration characteristics were also
investigated in response to FBS conditioned media. Commercially obtained FBS has
been shown to attract tumor cells in vitro, due to a wide assortment of proteins contained
in it. Exosomes are also found in FBS. To test whether these exosomes play a role in the
governing of neurosphere motility, three experimental conditions were tested using the
transwell assay; normal FBS, exosome free FBS and MEME containing isolated FBS
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exosomes. To my knowledge, this is the first study to investigate the effects of FBS on
neurosphere motility.
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CHAPTER TWO: ISOLATION, PROLIFERATION AND DIFFERENTIATION OF
MURINE NEURAL STEM CELLS:

BACKGROUND
Neural stem cells can be isolated from the adult brain. The region known as the
sub-ventricular zone contains a high concentration of NSCs and is a common target for
isolation procedures. Not all cells within the SVZ are NSCs however. To confirm the
presence of NSCs, the SVZ isolate must be passed in culture a minimum of seven times
using the neurosphere culturing method. Finally, the cultured cells must be differentiated
into the three common cells of the CNS; astrocytes, oligodendrocytes and neurons.

MATERIALS AND METHODS
SUBVENTRICULAR ZONE ISOLATION
Mice, strain C57BL/6, obtained from Harlan Laboratories were euthanized
through the approved IACUC protocol # 060. The mice were saturated with 70% ethanol
to reduce the risk of contamination. The dissections occurred under sterile conditions and
began with the decapitation of the mouse. The optic tract was separated from the eyes by
making a small incision behind the orbital bones. The scissors were inserted on the
posterior – dorsal portion of the head and between the scalp and calvaria. An anterior
slice to the snout allowed the scalp to be peeled aside exposing the occipital bone. A
shallow cut beginning at the occipital bone, up through the sagittal suture and through the
frontal bone gave access to the brain. Once the cranial bones were peeled aside, the brain
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(no longer attached to the spinal column and optic tracts) was gently teased out of the
cranium.
The extracted brain was placed into a petri dish containing phosphate buffered
saline (PBS) with 2% glucose on its dorsal side exposing the ventral region and the
clearly visible optic chiasm. A sterile blade was used to slice down through the optic
chiasm resulting in anterior and posterior sections. A clean vertical slice in the previous
step was important to minimize the damage to the SVZ. The posterior section is
discarded and the anterior portion of the brain was positioned caudal side up. The now
visible SVZ was removed using forceps and placed into a centrifuge tube containing
PBS supplemented with 2% glucose.

NEUROSPHERE CULTURING
Once the SVZ isolates have settled at the bottom of the centrifuge tube (Biologix
Research Co.), the glucose solution is removed and the cells are re-suspended in 2.0 mL
of “complete” Neurocult NSC Proliferation Medium (mouse) (Stem Cell Technologies,
Vancouver, BC.). Complete media is prepared as follows: 1.0 mL of Neurocult NSC
Proliferation supplements (mouse) is added to every 9.0 mL of “Basal” Neurocult NSC
Proliferation Medium (mouse). Next, 1.0 µL of 10 µg/mL rh-FGF-b (fibroblast growth
factor) is added to every 1.0 mL complete media, followed by the addition of 20 ng/mL
rh-EGF (2.0 µL for every 1.0 mL complete proliferation media) and 2.0 µg/mL Heparin
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(1.0 µl for every 1.0 mL complete media). All reagents were obtained from Stem Cell
Technologies.
Cells were re-suspended through mechanical trituration using a 1000 µL pipette.
After approximately 50 triturations being careful not to introduce air bubbles, much of
the SVZ will have dissociated into single cells. The suspension was removed and filtered
through an 80 µm filter (BD Falcon, Sparks MD) into a new centrifuge tube to ensure a
single cell suspension. Any tissue remaining in the original sample was re-suspended in
2.0 mL complete media, and the procedure was repeated as necessary. The resulting
suspension was pelleted by centrifugation at 150 x g for 5 minutes (Eppendorf, Hamburg,
Germany). Again the supernatant was removed and the cells are gently re-suspended in
2.0 mL of complete media. The cells were counted using 0.4% trypan blue stain (GibcoInvitrogen, Carlsbad, CA.) and a hemocytometer (American Optical, Southbridge, MA.)
and plated at 2 x 106 cells / 10.0 mL complete media in a T-25 cm2 flask (Nunc,
Roskilde, Denmark). Neurospheres begin forming within 24 hours and detach from the
plate within 48 hours. The cultures are passed when the neurosphere colonies become
visible to the naked eye but before the medium becomes acidic, indicated by a color
change of the media indicator.
When neurospheres are ready for passage, the entire culture suspension is
collected and centrifuged at 150 x g for 7 minutes. The supernatant is discarded and the
pellet is re-suspended in 2.0 mL of complete proliferation media. Gentle trituration
separates the neurospheres into a single cell suspension. At this point, the cells are again
counted using trypan blue and a hemacytometer. The cells are seeded at a density of 5 x
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105 / 10.0 mL for a T-25 cm2 flask at each subsequent passage. Between passages,
neurospheres were cultured at 37oC and 5.0% CO2 (Revco, Twinsburg, OH.).

DIFFERENTIATION ASSAY
Once neurospheres have been passed greater than seven times, they must be
differentiated to definitively claim the presence of NSCs. To differentiate, neurospheres
are pelleted by centrifugation at 90 x g for 5 minutes. The complete proliferation media is
aspirated and the pellet is re-suspended in 10.0 mL of Complete Neurocult NSC
Differentiation Medium (mouse). A solution of nine parts Neurocult NSC Differentiation
Basal Media is added to one part Neurocult NSC Differentiation Supplements to create
the Complete medium. The suspension is again centrifuged, (90 x g for 5 minutes) after
which the supernatant is removed. Pelleted neurospheres are re-suspended in 2.0 mL of
Complete Differentiation Media and a single cell suspension is obtained using gentle
mechanical dissociation. A cell count is performed as described previously and cells are
plated at a density of 5 x 104 cells/well in 24 well plates. A poly-l-ornithine coverslip
(Becton-Dickinson, Franklin Lakes, NJ.) is placed in each well prior to the addition of
cells. After 6-8 days, the plates are checked using an inverted light microscope
(Microscoptics Incorporated, Holly, MI.) to establish the viability of the cells. If viable,
differentiation status can be determined looking at cell morphology. Differentiated cells
will spread out on the cover slips and heterogeneous cell populations will be observed.
All of the differentiation media and supplements were purchased from Stem Cell
Technologies.
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IMMUNOLABELING PROCEDURE
For wells with differentiated cells, the cover slips are transferred to new 24 well
plates containing 1.0 mL of 4% paraformaldehyde in PBS pH 7.4 (Gibco-Invitrogen).
After a 30 minute incubation the paraformaldehyde is aspirated and the cells are
permeabilized by the addition of 1.0 mL of PBS containing 0.3% Triton X-100 (Fisher
Scientific, Hampton, NH). Following a five minute incubation, the Triton X-100 solution
is removed and the cover slips are washed three times using PBS. The cells are now
ready to be antibody (Ab) labeled. The primary antibodies used were: Mouse IgG antimicrotubule associated protein 2 (MAP2, neurons), rabbit polyclonal glial fibrillary
acidic protein (GFAP, astrocytes) and mouse oligodendrocyte IgM marker O4. The
working dilutions for the primary antibodies were as follows; MAP2 – 1:200, GFAP –
1:100 and O4 – 1:50. Each primary antibody was diluted to a working concentration with
PBS enriched with 10% goat serum. The antibodies were then added to the 24-well plate
at a volume of 200 µL. The plates were incubated for 2 hours at 37oC before washing 3
times (5 minutes each) with PBS.
To the appropriate wells, 250 μL of secondary antibody was added. The
secondary antibodies were added to each well at a volume of 200 µL. The secondary
antibodies used were FITC-conjugated Affini-Pure goat anti-mouse IgM, µ chain
specific, FITC-conjugated Affini-Pure goat anti-rabbit IgG (H + L) and Texas Red
conjugated goat anti-mouse IgG. The working dilutions were 1:100 for the FITCconjugated Abs, and 1:75 for the Texas Red conjugated Ab. After a 30 minute
incubation at 370C unbound Ab was washed off using three PBS washes (five minutes
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each). After the final wash, 200 μL of distilled water (dH2O) was added to each well (all
primary and secondary Abs were obtained from Stem Cell Technologies). Cover slips
were transferred from the dH2O to a microscope slide and were mounted using a single
drop of Vectashield mounting medium with 4',6-diamidino-2-phenylindole (DAPI)
(Vector Laboratories Incorporated, Burlingame, CA.). The slips were visualized using
fluorescent microscopy. The filters used to visualize each flourochrome are shown in
Table 1.

Table 1: Immunostaining Fluorochromes. The following fluorochromes were used for
the immunostaining of neurospheres during the differentiation assay.

Fluorochrome

Absorption peak (nm)

Emission peak (nm)

Fluorescein, FITC

492

520

Texas Red, TR

596

620

DAPI

350

460

RESULTS
The cells isolated from the mouse SVZ were placed into culture and began
forming neurospheres within 24 hours (Figure 1). By day four, the media became acidic
and the cells were passed. This procedure was continued and the cells were passed a total
of 27 times. The cells were typically passed every six days; with an average growth
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range of 5-7 days. During each passage, the cells were counted (Figure 2). Even at P27,
the neurospheres were able to repopulate the flask within seven days.

Figure 1: Image taken of P3 cells isolated from the mouse SVZ. (A) A Floating
neurosphere in the signature spheroid profile. (B) Early passages contained cells not
derived in the central nervous system such as red blood cells (RBCs). These cells were
typically smaller, did not form neurospheres, and stayed attached to the base of the flask.
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Figure 2: Continued proliferation of cells isolated from the mouse SVZ. Cells were
passed every 5-7 days at a concentration of 5 x 105 cells / 10.0 mL of complete
proliferation media. During each passage, the total number of cells was recorded.

After passing the neurospheres to the P7 stage, differentiation into the three CNS
cell types was necessary to confirm the presence of stem cells. The differentiation assay
was performed using the Stem Cell Technologies Differentiation Assay protocol
described previously. The only change to the protocol was the addition of the nucleus
stain, DAPI, during the mounting step. Positive staining was observed with DAPI as well
as the oligodendrocyte marker, O4-FITC conjugated. The Texas-Red and MAP2 samples
(astrocyte and neuron markers respectively) were negative. The Texas-Red conjugated
secondary antibody was negative in the sample containing all three primary antibodies
(Data not shown). FITC labeling was positive in the sample containing the three primary
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antibodies, but the presence could not be definitively linked to the presence of neurons
since FITC was used in the secondary antibody for both neurons and oligodendrocytes.
These findings indicate that the neurospheres were un-able to differentiate into the three
common cells of the CNS.

DISCUSSION
The stem cell isolation was conducted on two separate occasions. For the first
attempt, the SVZ of the mice brains were isolated and dissociated as the protocol
describes. The cells were placed into culture without performing cell counts. These cells
were then incubated for 48 hours before microscopic observation was performed. At the
48 hour point, the media had turned yellow indicating a decrease in pH. The culture
media was cloudy, a possible indication of bacterial contamination. The media was
replaced and streptomycin was added at a concentration of 100 μg / L. After 48 hours,
the media displayed the previous characteristics, and were deemed contaminated and
discarded.
A second isolation was performed as before, this time however, the cells were
counted prior to plating. The cells were plated at a density of 2 x 106 cells / 10 mL of
media per plate. The cells were observed regularly and neurospheres formed quickly.
Even at this density the media became acidic and the plates filled rapidly with cells. The
initial observance of neurospheres gave confidence during the first few cell passings and
by P4 the culture media appeared uncontaminated. Because the initial cell propagation
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was rapid, it is possible that the “contamination” observed during the initial isolation was
caused by an overabundance of cells. It is even more likely since the initial cultures were
not of a known cell density and thus an extremely large number of cells could have been
plated.
The neurospheres obtained during the second isolation were eventually passed to
P27. It was a decision of the investigator to stop passage of the neurospheres, not due to
contamination or an inability propagate. The cells were observed microscopically during
and between each passage and the cells forming the neurospheres were much smaller
than expected. Initially it was thought the cells were RBCs that had clumped together.
However the ability of the cells to repopulate the cell plates indicated the cells were
proliferating ruling out RBCs. It was also suggested that the proliferating cells were
possibly prokaryotic in origin. However, this hypothesis was rejected by the positive
nucleus staining with DAPI. Informal consultations with stem cell experts also confirmed
the relatively small physical appearance of stem cells in culture.
The ability to repopulate the cell plates along with the positive DAPI staining was
compelling evidence that the cells forming the neurospheres were eukaryotic. The
formation of neurospheres at P27 was also suggestive to the presence of stem/progenitor
cells since the formation of neurospheres post P7 is typically sufficient to claim SC
existence. The final test in the determination of the presence of SCs was the
differentiation assay. In its most basic form, the differentiation assay is simply a change
in media that triggers cells to undergo progression down their innate lineage.
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The first step of the differentiation assay was plating the cells, forming the
neurospheres, on poly-L-ornithine coated slides in differentiation media. During this
time cells should stop proliferating and begin differentiating. The majority of cells
continued proliferating with only a small number attaching to the cover slips. The result
of which were very small sample sizes on each slip. The washing steps caused additional
removal of cells compounding the sample size issue. The poor results of the
differentiation assay can be attributed, at least in part, to the small number of cells on
each slide. The observation of FITC labeling of the 04 marker was encouraging. The
labeling indicates that the cells were in-fact differentiating. A differentiation assay with
clear positive results for each of the cell markers is necessary before confirmation of
stem/progenitor cell presence can be made. For this reason, the cells isolated from the
SVZ will be referred to from this point forward simply as neurospheres.
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CHAPTER THREE: STROMAL DERIVED FACTOR 1α (SDF-1α) AND FETAL
BOVINE SERUM (FBS) INDUCED MIGRATION OF SVZ DERIVED
NEUROSPHERES:

BACKGROUND
When separated from a chemokine source, NSCs display polarity in their
movement either towards or away from the source depending on the ligand. Chemokines
play an important role in the body’s normal functions as well as cancer formation and
progression. To form a tumor mass, cancer cells must have a constant supply of nutrients.
Through the process of angiogenesis, GBMs are able to overcome hypoxia and continue
to proliferate. Angiogenesis is induced, in part, through the release of the hypoxia-related
chemokine SDF-1α. Previous research has indicated that SDF-1α interacts with the cell
surface receptor CXCR4 to promote cell migration (Ehtesham et al.). It was therefore of
interest to determine whether the neurospheres isolated from the SVZ would respond in a
similar manner. Also of interest was the effect FBS would have on neurosphere
migration. Cancer cell migration assays from our own laboratory have indicated that FBS
acts as a strong chemo-attractant (data not shown). It was hypothesized to also induce
migration of neurospheres in an attractive manner. Both studies were performed in order
to gain a better understanding of the neurosphere migration capabilities.
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MATERIALS AND METHODS
TRANSWELL ASSAY
The QCMTM 24-Well Colorimetric Cell Migration Assay was commercially
obtained from Chemicon International. A general diagram of the transwell assay is shown
in figure 3. The first step was to prepare the media placed into the outer chamber. To test
the effect of FBS, 9.0 mL of minimum essential medium eagle (MEME), (BioWhittaker
Incorporated, Walkersville, MD.) was mixed with 1.0 mL of FBS (PAA Laboratories,
Pasching, Austria) yielding a 10% FBS solution. A total of 500 μL was taken out of the
10% FBS solution and placed into each of the outer chambers. Into the inner chamber,
300 μL of neurospheres at a density of 7 x 105 cells / 1.0 mL were seeded. The inner
chamber was then placed into the outer chamber and incubated at 370C and 5% CO2 for
20 hours. The procedure was repeated for the experiments involving SDF-1α. The SDF1α was tested at concentrations of 25.0, 50.0, 100.0 and 200.0 ng/mg in MEME. Each
condition was repeated at least three times (three wells) for each of the migration
experiments. An example of the SDF-1α assay is depicted in figure 4.
During the incubation, cells are free to migrate. The inner chamber contained
pores 8.0 μm in diameter. These pores are small enough to inhibit the passive passage due
to gravity, but large enough to allow a cell to actively pass through. Once through the
pores, the neurospheres remain suspended in the media or settle to the base of the outer
chamber. These cells were then physically scraped off the floor of the outer chamber, and
quantified using the Cell Titer-Glo assay (Promega, Fitchburg, WI.). Cells that had
detached from the underside of the inner chamber were not collected.
31

In addition to each experimental sample, a group of five control samples were
assayed using the transwell assay. As a negative control, unmodified MEME was used in
the outer chamber of the assay. The control indicated the total random migration of the
neurospheres during each assay. To measure a relative quantity of migratory
neurospheres, the Cell Titer-Glo assay was used.

Figure 3: Transwell Assay. (A) 300 μL of Neurospheres are placed into the inner
chamber at a density of 7 x 105 cells / 1.0 mL. The inner chamber is inserted into the
outer chamber containing the experimental solution. The assay is then incubated to allow
the cells to migrate through the pores. (B) Cells that have migrated from the inner
chamber into the outer chamber were quantified using the Cell Titer Glo assay.
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Figure 4: Transwell assay sample preparation. First, the experimental solution was made
(100 ng/mL SDF-1α). The solution was then used in three transwell assay chambers
(A,B,C). After the incubation period, the cell suspension in each of the three chambers
was subdivided into five separate wells for quantification using the Cell Titer Glo assay.

CELL TITER- GLO ASSAY
After the 20 hour incubation, the inner chamber was removed from the outer
chamber and discarded. Each outer chamber was manually scraped to re-suspend the
migratory neurospheres. From each suspension, five - 100 μL samples were transferred to
five individual wells of an opaque bottom 96-well plate (Becton-Dickson - Falcon). To
each sample, 100 μL of the complete Cell Titer Glo reagent was added. The complete
Cell Titer Glo reagent was prepared by adding 10.0 mL of the Cell Titer Glo solvent to
the Cell Titer Glo substrate. The plate was incubated at room temperature and rocked
gently using a random orbital shaker (Stovall – Thermoscientific, Waltham, MA) for
three minutes. The plates were then removed from the shaker and incubated for another
10 minutes at room temperature. Relative Light Units (RLUs) were obtained for each
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well by measuring luminescence using the Modulus plate reader (Promega). For each
transwell assay, background luminescence was determined by adding 100 μL of complete
reagent to 100 μL of un-modified MEME.

RESULTS
The SDF-1α enriched MEME induced an increase in neurosphere migration as
expected. At concentrations of 100.0 ng/mL and 50.0 ng/mL, the SDF-1α induced a
statistically significant increase in neurosphere migration compared to the control (Figure
5). The 25.0 ng/mL sample was unable to induce any change in neurosphere motility
(Figure 5). The 25.0 ng/mL sample was tested during three migration assays, each with a
similar outcome. The final concentration of 200.0 ng/mL also generated significant
change in migration, albeit acting as a chemo-repellent. This finding correlates with prior
research that has found SDF-1α to act as a chemo-repellent in high concentrations
(Poznansky et al.). Taken together, the data indicates that the chemo-attractive effect of
SDF-1α on neurosphere migration is concentration dependent.
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Figure 5: SDF-1α induced migration of neurospheres is concentration dependant. (1)
Control – unmodified MEME, (2) 200.0 ng/mL SDF-1α (3) 100.0 ng/mL SDF-1α (4)
50.0 ng/mL SDF-1α (5) 25.0 ng/mL SDF-1α. Bars 3 and 4 induced a statistically
significant increase in neurosphere migration. Bars 2 also reached statistical significance,
but acted as a chemo-repellent. P value ≤ 0.01. The 25.0 ng/mL SDF-1α did not cause a
change in neurosphere migration. All samples were analyzed using a student’s t-test.

The second arm of the experimental set determined whether the presence of FBS
stimulated a change in neurosphere migration. When MEME was supplemented with
10% un-modified FBS, a significant change (P ≤ 0.001) in neurosphere motility was
observed (Figure 6). The addition of FBS caused a significant decrease in neurosphere
migration when compared to the control. To test the validity of the initial findings, the
experiment was repeated twice more, each with the same outcome. These findings, along
with the other two trials (data not shown), indicate that FBS influences neurospheres in a
chemo-repellent manner.
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Figure 6: Effect of MEME + 10% FBS on neurosphere migration. The addition of 10%
un-modified FBS caused a statistically significant reduction in neurosphere migration
(P ≤ 0.001).

DISCUSSION
An extensive literature review indicated that SDF-1 was a chemo-attractant
capable of justifying the alternative recurrence model. The study performed here was
able to achieve a statistically significant increase in neurosphere migration toward SDF1α (50.0 and 100.0 ng/mL concentrations), in a concentration dependent manner. Three
separate transwell assays were performed using SDF-1 at a concentration of 25.0
ng/mL, none of which caused a significant change in overall migration rates. The
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concentration of SDF-1α necessary to induce migration was larger than expected but fell
within the recommended concentrations.
One possible explanation lies in the different species of origin of the neurospheres
and the SDF-1. The neurospheres were isolated from a mouse, while the SDF-1 was of
human origin. The SDF-1 was of human origin since the GBM cell lines to be utilized
during the later portions of the experiments were also of human origin. To determine if
the species differences were of importance, the protein sequences were analyzed for
homology. The differences between the human and murine SDF-1 are quite slim with
roughly 92% homology (Entrez-Gene). The receptor, CXCR4, is also similar between
species with a 91% homology between murine and human (Entrez-Gene). The highly
conserved nature of both the ligand and receptor indicates both the importance of the
interaction between species, as well as the likelihood that human SDF-1 can interact
with the murine CXCR4. It seems likely then that the high concentration threshold of
SDF-1α is not the result of a sequence difference between species. The mechanisms
behind the concentration threshold may require future research to further elucidate the
mechanism(s). However, the high threshold may not be of real importance but rather a
curiosity to the investigator.
The other interesting observation was the chemo-repellent effect of the 200.0
ng/mL SDF-1α. Recent studies have indicated that T-cell migration is controlled, at least
in part, by the SDF-1α – CXCR4 interaction (Poznansky et al.). It was found that at
concentrations greater than 100 nM, SDF-1α repels T cells in a CXCR4 dependant
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manner. The findings within this study support the concept that SDF-1α acts as both an
attractant and repellent in a concentration dependant manner.
The most surprising outcome from the set of experiments was the chemo-repellent
nature of FBS on neurosphere migration. Proteomic screens have indicated that FBS is
rich in chemo-attractive proteins, a finding supported by findings within our own lab, that
GBM cells will migrate towards FBS enriched media. The data presented within this
study clearly demonstrates that neurospheres were repulsed by the MEME + 10% FBS.
The cause of the repulsion has yet to be clearly elucidated, but a few causes are possible.
For the same reason that neurospheres were un-responsive to SDF-1α at
concentrations of 25.0 ng/mL, it is likely the chemo-attractants within the un-modified
FBS (including SDF-1α), were at concentrations below the threshold necessary induce
neurosphere migration. The low levels of chemo-attractants would thus explain the lack
of attractiveness towards the FBS enriched media. Furthermore FBS contains a wide
array of proteins including chemo-repellents. A possible sensitivity to chemo-repellents
with a resistance to moderate levels of SDF-1α would explain the repulsive effect of FBS
on the neurospheres.
The repulsive effects of the MEME + 10% FBs upon the neurospheres could also
be an innate response based on the cell composition of the neurospheres. Research has
indicated that CSC cultures from primary brain tumors grown as neurospheres exhibit
characteristics opposite those of cells of the same origin grown in the presence of serum.
For instance, primary cultures grown in serum begin differentiating within days while
cells of the same origin grown as neurospheres remain undifferentiated for over a year
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(deCarvalho et al.). Even after a year the neurospheres will differentiate into the cells of
the CNS when transferred to serum containing media. Primary cultures grown in serum
have also been compared neurosphere cultures after implantation into mice (Li et al.).
The invasiveness of each culture was analyzed and the results indicated that neurospheres
were much more invasive than the differentiated cells of the serum containing cultures.
A second experiment determined that the passage number of the serum containing
cultures also played a role in invasiveness with later passages being more invasive
(deCarvalho et al.). One important commonality between these studies was that while
primary cultures in serum and primary cultures in stem cell media can be of the same
origin, the cells quickly diverge in terms of phenotypic characteristics and even genomic
makeup. The end result of the divergence are two distinct cell types with separate
characteristics.
The same general concept can be applied to the results observed in this study. It
is possible that the neurospheres begin differentiating in the presence of FBS into the
different cell lineages during the 20 hour migration incubation. If true, these newly
differentiated cells could be less invasive (migrate less) than the cells of the control group
in serum free media (ie: those that still have the neurosphere phenotype). Testing this
hypothesis may be difficult after an incubation of only 20 hours. One possibility would
be to test the levels of SOX2 in the neurospheres before and after the transwell assay.
The undifferentiated stem cells should have a much higher expression of SOX2 than
would cells beginning to undergo differentiation (Masui et al.). This test would
strengthen the hypothesis, as SOX2 expression is an indicator of differentiation status.
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CHAPTER FOUR: THE INFLUENCE OF GBM CELL LINES ON THE MIGRATION
OF NEUROSPHERES ISOLATED FROM THE SVZ:

BACKGROUND
Glioblastomas are known to release chemokines under hypoxic and high stress
conditions in vivo. Stress can be applied to GBM cell cultures in vitro to induce a similar
release of chemokines simulating an in vivo response. The alternative recurrence model
predicts the hypoxia-induced release of SDF-1α by GBMs in vivo induces the migration
of neurospheres towards the tumor. To test, GBM cell lines were stressed using nutrient
and oxygen deprivation. Under these conditions, the cells were expected to release
chemokines which in turn would cause a change in neurosphere migration. The transwell
assay was performed to determine if the nutrient deprivation of GBM cell lines did in fact
cause a change in neurosphere migration.

MATERIALS AND METHODS
CELL LINES
Three human glioma cell lines were obtained from the American Type Culture
Collection (ATCC, Manassas, VA). The cell lines were T98 G, U-138 MG and the U-87
MG. The T98G cell line (ATCC# CRL-1690) was derived from a 61-year-10 month old
caucasian male in 1979. This particular cell line is classified as a glioblastoma
multiforme with fibroblast morphology and is grown in Minimum Essential Medium –
Eagle’s (MEME; ATCC), with 10% FBS supplement. The U-138 MG cell line (ATCC#
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HTB-16) was derived from a 47-year-old caucasian male. Pathologically, U-138 MG cell
line is a GBM with polygonal morphology, and is cultured in MEME, with 10% FBS.
The U-87 MG cell line (ATCC# HTB-14) was derived from a 44-year-old caucasian
female. The U-87 MG cell line is classified as a grade III astrocytoma and displays
epithelial morphology and was cultured in MEME with 10% FBS. All cell lines were
cultured at 37°C and a 5% CO2 atmosphere. Cells were passed on an as-needed basis
which was typically every three to four days, or when the monolayer of cell growth
covered more than 70% of the surface area of the flask. The cells were scraped from the
base of the flask to disrupt adhesion, and then aspirated with the medium into a collection
tube and centrifuged. The expended growth medium was aspirated and the cells were resuspended into fresh growth medium. The re-suspended cells were then plated at a
density approximately 25% of their previous density.

TRANSWELL ASSAY
The transwell assay was performed as described previously with the exception of
the following changes; For the first set of experiments GBM cell lines were plated into
the outer transwell chamber at a density of 5.0 – 7.5 x 105 cells / mL in un-supplemented
MEME. The cells were incubated for 24 hours before inserting the inner transwell
chamber. The remaining steps were carried out as previously described. For the second
set of experiments, GBM lines were cultured with un-supplemented MEME in sealed
culture flasks. The cultures were sealed to inhibit gas exchange and thus induce a
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hypoxic growth environment. After 24 hours the media was removed from the flask and
centrifuged (150 x g for 20 min) to remove suspended cells. The supernatant was
collected and centrifuged once more to further remove cellular debris from the
conditioned media. The collected media was termed GBM-conditioned media.
Complete cell removal was determined through the examination of the conditioned media
with an inverted light microscope. Cell-free, GBM-conditioned media was placed into the
outer transwell chamber and the migration assay was conducted. As a final experiment,
100 ng/mL SDF-1α was added to the GBM-conditioned media.

RESULTS
The effect of GBM cells on neurosphere migration was investigated in vitro using
the transwell assay. Three GBM cell lines; U87, U138 and T98 were used during the first
experiment. Each cell line was plated into the outer transwell chamber in serum-free,
unmodified MEME and deprived of oxygen. After 24 hours dissociated neurospheres
were plated into the inner transwell chamber. The results indicate that neurosphere
migration in the experimental groups differed from the control groups. There was a
significant reduction (P ≤ 0.001) in neurosphere migration when influenced by both the
T98 (Figure 7) and U87 cell lines (Figure 8). Migration of neurospheres also appears to
be reduced when separated from the U138 cell line (Figure 8) however the reduction in
migration failed to reach statistical significance. Similar results were observed in two
subsequent trials (data not shown). Taken together, GBM cell lines govern neurosphere
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migration in a chemo-repellent manner as demonstrated using the transwell migration
assay.

Relative Light Units (RLU)
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Figure 7: The chemotactic effect of the T98 GBM cell line on SVZ isolated
neurospheres. When compared to the control group, the T98s induced a significant
reduction in neurosphere migration (P ≤ 0.001).
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Figure 8: The effect of the U87 and U138 GBM cell lines on the migration of SVZ
neurospheres. Both GBM cell lines caused a reduction in neurosphere migration,
however, only the U87 cell line reached statistical significance (P ≤ 0.001).
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The change in neurosphere migration was thought to be due to the release of
soluble chemokines from the GBM cell lines. To test the validity of the assumption,
GBM-conditioned media was utilized in the second series of assays. The GBMconditioned media from each of the three cell lines was found to alter neurosphere
migration in a chemo-repellent fashion. Conditioned media from the three cell lines;
U87, U138 and T98 caused a statistically significant reduction in neurosphere migration
(Figure 9). These findings provide evidence that GBMs act in a chemo-repellant manner
upon neurospheres through the release of chemokines or soluble factors in vitro.
The final experiment investigated the effect of an exogenous addition of 100.0
ng/mL SDF-1α to the GBM-conditioned media samples. It was hypothesized the
addition would negate the repulsive effect of the GBMs. This hypothesis was supported,
as SDF-1α addition caused a significant change in neurosphere migration resulting in an
overall increase in neurosphere migration (Figure 10). It should be noted the SDF-1α
addition did not bring the neurosphere migration back to the levels observed with the
control groups.
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Figure 9: Effect of GBM-conditioned media from the T98, U87 and U138 cell lines on
neurosphere migration. All three cell lines caused a statistically significant (P ≤ 0.001)
reduction in neurosphere migration when compared to the control. These findings
support the GBM induced neurosphere repulsion found previously, indicating the
observed effects are due to chemokine release.
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Figure 10: Effect of exogenous addition of 100.0 ng/mL SDF-1α to GBM-conditioned
media. The U87 and U138 cell lines caused significant reduction in neurosphere
migration compared to the control. The addition of SDF-1α to the conditioned media
caused a significant increase in migration for both cell lines. (P ≤ 0.001)

DISCUSSION
To overcome the growth limitations of hypoxia, gliomas release SDF-1α and
VEGF. Together, these proteins promote the recruitment of endothelial progenitor cells
and subsequently the formation of new blood vessels. While the role in angiogenesis is
quite clear, side effects of SDF-1α release have yet to be fully elucidated. Hypothesized
here is a possible role in tumor recurrence and metastasis. The same attractive properties
exerted on the EPCs could extend to other cell types including stem cells / neurospheres.
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Attraction of these cells could be the first step towards the formation of a secondary
tumor, as hypothesized by the alternative recurrence model.
The attractive nature of exogenous SDF-1α as observed in the previous
experiments was the basis for determining whether GBM cell line released factors
(including SDF-1α) would be sufficient to induce a similar effect on neurosphere
migration. Glioma cell lines were deprived of nutrients, including oxygen, for 24 hours
prior to being used in the assay. The nutrient deprivation was thought to induce the
release of hypoxia related proteins. It was hypothesized that the SDF-1α release under
these conditions would thus increase. This SDF-1α increase would then attract
neurospheres, an effect measurable using a transwell assay. Under these conditions
however, the GBM cell lines did not cause an increase in neurosphere migration but
rather a significant decrease when compared to control groups.
Glioma-conditioned media was utilized in the second series of experiments and
yielded many benefits over culturing the GBM cells within the outer transwell chamber.
First, the exclusion of GBM cells from the transwell assay would confirm the repulsive
effects were due to the release of soluble factors and not the physical presence of the
cells. This in-turn would eliminate the possibility of a physical GBM - neurosphere
interaction causing the repulsion. Secondly, by removing the GBM cells from the outer
chamber, cells collected post-migration from the outer chamber would be exclusively
neurospheres. This allowed for an accurate migration quantification. The final advantage
of using conditioned media was that gas exchange could be prevented during the
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incubation stage. This yielded a better simulation of hypoxia and a hypothesized increase
in SDF-1α release.
The results from the second set of experiments clearly confirmed the initial
findings. The GBM-conditioned media caused a significant reduction in neurosphere
migration when compared to the control groups. Further, the repulsive effects of the
GBM cell lines could be conclusively linked to the release of proteins into the culture
media and not due to a physical interaction between the GBM cells and the neurospheres.
While the data appears to refute the hypothesized alternative recurrence model, it does
indicate that GBMs govern neurosphere migration behaviors in the transwell assay.
The second set of experiments also aimed to determine whether the repulsive
nature of GBM-conditioned media could be reversed with the addition of exogenous
SDF-1α. The addition of 100.0 ng / mL SDF-1α did cause a significant attraction of
neurospheres when compared to GBM-conditioned media not enriched with SDF-1α.
Interestingly, the SDF-1α addition did not bring the neurosphere migration rates back to
the baseline levels observed with the control groups. Taken together, the results suggest
the neurospheres used in the study are either less sensitive to SDF-1α or highly sensitive
to chemo-repulsive proteins being released by the GBM cell lines.
The findings also indicated a need to determine the physiological relevance of the
hypoxia simulation used in the study. A determination of GBM released protein levels
before and after the 24 hour nutrient deprivation would answer whether the hypoxia
simulation had any effect on the GBM cell lines. Testing the protein levels after longer
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nutrient deprivation periods would also determine if an increase in nutrient deprivation
should be used in further studies.
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CHAPTER FIVE: SDF-1α CONCENTRATION IN HYPOXIA INDUCED GBM CELL
LINES

BACKGROUND
To overcome hypoxic conditions in vivo, GBMs release elevated levels of VEGF
and SDF-1α. Hypoxia can be simulated for cells cultured in vivo, as was performed
within this study. To determine whether the hypoxia induction caused the desired
increase in SDF-1α release, a sandwich enzyme linked immuno-sorbant assay (ELISA)
was performed. Levels of SDF-1α were measured at four time points, to evaluate the
effect of the hypoxia induction. The times points tested were nutrient deprivation periods
of 24, 48 and 72 hours. The SDF-1α level at each of the experimental time points was
then compared to the control group. The control group was GBM-cells grown in unsupplemented MEME with gas exchange allowed. A student’s t-test was performed to
determine statistical significance between samples. The result of which was an
evaluation of the effectiveness of the hypoxia simulation performed in the study.

MATERIALS AND METHODS
EXPERIMENTAL SAMPLES
The sandwich ELISA was utilized to determine SDF-1α concentrations released
by four common GBM cell lines. The GBM cell lines included the U87MG, U138MG,
T98G and SF-767s. The SF-767s were cultured in MEM + Glutamax (Gibco) and
supplemented with 10% FBS. The other GBM cell lines were cultured as described
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previously. Each cell line was plated at a density of 2 x 106 cells / 10.0 mL media
supplemented with 10% FBS. The cells were incubated for 24 hours under normal
culture conditions to allow the cells to attach to the floor of the culture dishes. After the
24 hour period, the FBS containing media was exchanged for un-supplemented media
and the cells were again incubated for 24 hours. To quantify the amount of SDF-1α
released by cells cultured in un-supplemented media with proper gas exchange,
supernatant samples were collected. Cells and cellular debris were then removed by the
centrifugation steps as described previously. The samples were then compared to a
standard curve prepared for each trial to quantify of SDF-1α levels for each cell line and
used as the control data.
Following the determination of baseline SDF-1α levels for each cell line, the
sandwich ELISA was used to determine the effect of the 24 hour nutrient deprivation.
Each cell line was plated at a concentration of 2 x 106 cells / 10.0 mL media
supplemented with 10% FBS. After 24 hours, the media was exchanged for 10.0 mL of
serum free media as described. At this time, the flasks were sealed to prevent gas
exchange. The cell lines were then incubated for 24 hours before samples of the media
were taken. The same procedure was repeated changing the final incubation to 48 hours
and then to 72 hours.
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SANDWICH ELISA
All reagent preparation was performed as specified by R and D Systems
(Minneapolis, MN.). After bringing the reagents to room temperature, 50 μL of assay
dilutent RD1-55 was added to each well. Next, 50 μL of Standard, Control or cell
supernatant was added to the dilutent containing wells. The plates were then incubated
for two hours at room temperature on an orbital shaker set to 500 rpm. Once the
incubation period was completed, the media was aspirated and each well was washed
with 400 μL of wash buffer four times. When the wells were completely dry, 100 μL of
mouse SDF-1α conjugate was added. Again, the plate was incubated for 2 hours at room
temperature on an orbital shaker. Incubation was followed by the aspiration/washing step
described previously and the subsequent addition of 200 μL of substrate solution to each
well. The plate was then incubated for 30 minutes in darkness before adding 50 μL of
stop solution to each well, the result of which was a color change based on the amount of
SDF-1α. Lastly, the optical density was recorded at 450 nm.
To prepare the experimental samples, the four cell lines were cultured as
described above. The hypoxic time points were arranged in a manner that allowed all
samples to be taken on the same day. From each culture plate, 7.0 mL of media was
removed, transferred to 15 mL conical tubes and centrifuged for 20 minutes at 150 x g.
The supernatant was removed after the centrifugation and the procedure was repeated, the
result of which was GBM-conditioned media devoid of both living and dead cells. From
each experimental sample, 25 μL of conditioned media was diluted with 225 μL of
Calibrator Diluent RD6Q as recommended by R and D Systems.
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RESULTS
To determine the SDF-1α concentrations in GBM-conditioned media, the SDF-1α
standard curve was constructed as recommended by R and D Systems (Figure 11). From
the standard curve, the line of best fit was calculated yielding the equation y = 0.000121x
+ 0.004221. The SDF-1α levels were determined using the line of best fit and the
corrected absorbance values from each experimental sample. The corrected absorbance
values were determined by subtracting the average absorbance of the 0 ng/mL SDF-1α
standard sample from the average absorbance value for each experimental sample.

Figure 11: SDF-1α standard curve. The standard curve was constructed as
recommended by the R and D Systems protocol. The equation obtained through the
construction of the line of best fit was used to determine the SDF-1α concentrations in the
GBM-conditioned media samples. The equation for the line of best fit was found to be
y = 0.000121x + 0.004221 with an R² = 0.997609.
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The sandwich ELISA was initially performed to determine the SDF-1α
concentration in GBM-conditioned media at a cell density of 2 x 106 cells / 10.0 mL
media (control groups). Each of the experimental samples yielded an average absorbance
between 0.11 and 0.12 at 450 nm (Figure 12). A student’s t-test was performed on the
average absorbance values, the data from which indicated that none of the experimental
samples were statistically different. Next, the average absorbance, and equation for the
line of best fit were used to calculate SDF-1α concentrations. The GBM samples were
initially diluted 10-fold for the sandwich ELISA so the SDF-1α concentrations were
multiplied by 10 to find the actual concentrations shown in table 2. The SDF-1α
concentrations for each cell line were as follows: 1190 pg / mL for the T98s, 525 pg / mL
for the SF767s and the U138 cell line released a negligible amount of SDF-1α (0.333
pg/mL). All three concentrations were below the exogenous levels necessary to induce
neurosphere migration. Due to the 10-fold dilutions of the initial GBM samples the U87
reading fell below the baseline level which meant that calculations could not be
performed on the sample.
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Figure 12: Average absorbance at 450 nm for the four cell lines tested using the SDF-1α
sandwich ELISA. None of the cell lines displayed an absorbance value that was
significantly different than any of the other cell lines. It is also important to note that the
samples taken from each cell line were diluted 10 fold as recommended by the
manufacturer.

Table 2: Results from the sandwich ELISA on the four GBM samples (U87, T98, U138
and SF767). The samples were tested for SDF-1α release. For each sample, the standard
deviation between samples is shown along with the average SDF-1α concentration. The
corrected absorbance was found by taking the average absorbance and subtracting the
“blank” recording. This calculation caused the U87 sample to fall below the threshold
for calculations.

Sample

Average Absorbance at
450 nm

Corrected
Absorbance

U87
T98
U138
SF767

0.1157
0.1316
0.1173
0.1236

0.002625
0.018525
0.004225
0.010525
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SDF-1α
Concentration
(pg/mL)
1190
0.333
525

A second trial was conducted in which the experimental samples were not diluted
in order to obtain SDF-1α levels for the U87 cell line. The precision of the initial trial
was also determined by performing a second trial. By not using the recommended 10fold dilution, each of the four GBM cell lines yielded SDF-1α concentrations. The U87,
T98, U138 and SF767 cell lines released SDF-1α concentrations of 107.5 pg / mL, 151.7
pg / mL, 152.5 pg / mL and 45.03 pg / mL respectively (Table 3). The data from the
second sandwich ELISA indicates GBM-conditioned SDF-1α concentrations are
magnitudes of order lower than the exogenous concentrations found to induce
neurosphere migration. After determining the concentrations for the four GBM cell lines,
a follow-up experiment was performed to determine the effect of longer nutrient
deprivation on the release of SDF-1α.

Table 3: Results from the second trial of the sandwich ELISA on the four GBM cell
lines. The conditioned media was not diluted prior to testing. Each sample resulted in a
corrected absorbance value above threshold for calculations. The resulting SDF-1α
concentrations were once again below the exogenous levels found to induce neurosphere
migration.
Sample

Average Absorbance
at 450 nm

Corrected
Absorbance

SDF-1α Concentration
(pg / mL)

U87

0.1302

0.017125

107.5

T98

0.1355

0.022425

151.7

U138

0.1356

0.022525

152.5

SF767

0.1227

0.009625

45.03
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To determine whether a longer nutrient deprivation would have caused a change
in concentrations, each sample was tested at four time points. SDF-1α concentrations
found in the conditioned media of nutrient deprived (including oxygen) GBM cultures of
24, 48, and 72 hours were compared to the control groups (Figure 13). A student’s t-test
was performed to compare the average absorbance of each experimental sample. Testing
of the four GBM cell lines found only the comparison of the T98 control to the T98 72hour deprivation sample reach statistical significance (Figure 13b). The average
absorbance of each sample was then used to determine the corrected absorbance values.
The corrected absorbance was subsequently drawn on to procure the SDF-1α
concentrations for each experimental sample (Table 4). For the U87 cell line, only the
corrected absorbance value for the 72-hour sample was large enough to calculate SDF-1α
concentrations (142 pg / mL). The four time points of the T98 cell line resulted in a wide
range of SDF-1α concentrations (209 pg / mL – 1950 pg / mL). Importantly, a positive
correlation was observed between the duration of nutrient deprivation and SDF-1α
release for the T98 samples. The corrected absorbance in the control group for the U138
cell line was too low to calculate the SDF-1α concentration. However, the same
correlation of nutrient deprivation and SDF-1α release was observed for the three time
points tested (0.33 pg / mL – 125 pg / mL). The SF767 cell line again followed the
positive correlation observed in the other cell lines (325 pg / mL – 1492 pg / mL).
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Effect of Nutrient Deprivation on U87
Released SDF-1
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Figure 13a: Average absorbance at 450 nm at differing time points for the U87 cell line
using the SDF-1α sandwich ELISA during the in vivo nutrient deprivation study. The
first column represents media taken from cells not deprived of nutrients. No significant
difference in SDF-1α release was obtained at any of the time points tested.
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Effect of Nutrient Deprivation on T98
Released SDF-1
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Figure 13b: Average absorbance at 450 nm at differing time points for the T98 cell line
using the SDF-1α sandwich ELISA during the in vivo nutrient deprivation study. The
first column indicates media taken from T98 control group (cells not nutrient deprived).
A significant increase in SDF-1α release was only observed at the 72 hour point.
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Effect of Nutrient Deprivation on U138
Released SDF-1
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Figure 13c: Average absorbance at 450 nm at differing time points for the U138 cell line
using the SDF-1α sandwich ELISA during the in vivo nutrient deprivation study. The
first column indicates media taken from the U138 control (not nutrient deprived). No
significant increase in SDF-1α was observed at any of the time points tested.

Effect of Nutrient Deprivation on
SF767 Release of SDF-1
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Figure 13d: Average absorbance at 450 nm at differing time points for the SF767 cell
line using the SDF-1α sandwich ELISA during the in vivo nutrient deprivation study.
The first column indicates media taken from SF767 control (not nutrient deprived). No
significant increase in SDF-1α was observed at any of the time points tested.
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Table 4: Time course sandwich ELISA. The four cell lines (U87, T98, U138 and SF767)
were tested using the sandwich ELISA procedure at increasing time points to determine
the effect nutrient deprivation had on overall SDF-1α release. A positive correlation
between SDF-1α release and increased nutrient deprivation is observed.
Corrected
Absorbance

SDF-1α Concentration
(pg / mL)

Sample

Average Absorbance
at 450 nm

U87

0.1151

U87 (24)

0.1157

.002625

-

U87 (48)

0.1169

.003825

-

U87 (72)

0.119

.005925

142

T98

0.1198

.006725

209

T98 (24)

0.1316

.018525

1190

T98 (48)

0.1297

.016625

1034

T98 (72)

0.1407

.027625

1950

U138

0.1172

.004125

-

U138 (24)

0.1173

.004225

0.333

U138 (48)

0.118

.004925

58.7

U138 (72)

0.1188

.005725

125

SF767

0.1212

.008125

325

SF767 (24)

0.1236

.010525

525

SF767 (48)

0.1267

.013625

784

SF767 (72)

0.1352

.022125

1492

.002025
-
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DISCUSSION
At the time of writing, no data has been published on GBM released SDF-1α
concentrations. The one published piece of data on SDF-1α quantification looked at
release by human dental pulp cells. The study found that SDF-1α was released at a
concentration of 45133 ng / L (45 ng / mL) (Gong et al.). Based on the limited
information available, it is hypothesized that exogenous SDF-1α levels necessary to
induce neurosphere migration in this study were far greater than levels released by the
GBM cell lines. Even so, it was of interest to the investigator to determine the SDF-1α
concentrations released by the GBM cell lines used in the transwell assay.
The GBM cell lines were cultured at a density of 2 x 106 cells / culture. At this
density, SDF-1α concentrations were expected to be below the 45 ng / mL found in the
prior study. The transwell assays performed previously found migration to be
concentration dependant, with a necessary SDF-1α concentration of 50 ng / mL. In order
for GBM cell lines to induce similar neurosphere migration, the SDF-1α levels in the
conditioned media would be expected to be near the 50 ng / mL threshold. Any
concentration below the threshold would explain the inability of conditioned media to
attract the neurospheres. To test the validity of this theory, the 24-hour GBM conditioned media (the same time point used in the previous transwell assays) was tested
to determine SDF-1α concentrations. The concentrations varied between cell lines (0.33
pg/mL for the U138 cell line – 1190 pg/mL in the T98 cell line), however, none of the
samples approached the exogenous 50 ng/mL threshold. The findings confirm that 24hour nutrient deprivation of GBM cell lines does not induce the release of SDF-1α at
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concentrations possible of attracting the isolated SVZ neurospheres using the transwell
assay.
The findings of the 24-hour deprivation were analyzed to determine the efficacy
of the nutrient deprivation. The transwell assays used 24-hour nutrient deprivation to
induce the release of SDF-1α. The sandwich ELISA was used again to determine if a
longer nutrient deprivation period would increase SDF-1α release. Time points of 48 and
72 hours were compared to the 24 hour time point and a control of MEME containing
FBS. The data indicated the 24-hour deprivation did not cause a significant increase in
SDF-1α concentrations compared to the control. The data did indicate a positive
correlation between an increase in the duration of nutrient deprivation and SDF-1α
release. However, only the 72-hour time point in the SF767 cell line reached statistical
significance.
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CHAPTER SIX: INVOLVEMENT OF THE NEUROPILIN-1 – SEMA3A
INTERACTION AS AN EXPLANATION FOR NEUROSPHERE REPULSION:

BACKGROUND
Due to the chemo-repulsive influence of GBM cell lines on neurosphere
migration, a literature review was performed to find a candidate responsible for the
effect. The review led to the hypothesis that GBM cell lines may release an elevated
level of Sema3A, a member of the semaphorin family of proteins (Goshima, Ito et al.). If
the neurospheres were expressing the receptor to Sema3A, Nrp-1, the interaction would
cause chemotaxis in a repulsive manner. To determine whether the hypothesis was
possible, real time PCR was performed on neurosphere lysate in hopes of finding Nrp-1
mRNA.
RNA extraction was used to obtain intact Nrp-1 mRNA strands. A blast search
was used in order to build complementary forward and reverse mRNA primers specific to
the Nrp-1 mRNA (Integrated DNA Technologies, Coralville, IA.).

The forward primer used the sequence:
5’ – TGG GAA GAT TGC ACC TTC TCC TGT – 3’
The reverse primer used the sequence:
5’ – TTC TGC CCA CAA TAA CGC CCA ATG – 3’
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Used together, the primers resulted in an overall amplification of a 381 BP sequence of
the Nrp-1 mRNA. The calculation for the amplified sequence length would be important
for determining whether an amplified sequence was from the Nrp-1 mRNA.

MATERIALS AND METHODS
RNA EXTRACTION
RNA was extracted from the isolated neurospheres by using the spin column
protocol for animal cells in the manufacturer’s published protocols for the RNeasy Kit
(Qiagen, Hilden, Germany). The buffer RLT, which contains guanidine thiocyanate, was
used to lyse the cells in highly denaturing conditions. Under these conditions, RNases
become inactive allowing for the purification of intact RNA. Homogenization of the
cells was then performed by passing the cells through a QIAshredder homogenizer
(Qiagen). The addition of 70% ethanol to the lysate promotes selective binding of RNA
to the spin column membrane. The spin column was then washed to remove
contaminates, and the RNA was eluted in RNase-free water. The samples were used
within 1 hour of RNA extraction.
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REAL TIME - POLYMERASE CHAIN REACTION (RT - PCR)
Dilution of the primers was performed to prepare the master mix. For example,
an 8 sample experiment would dilute 8 µL of primer into 72 µL of nuclease free water.
Once each primer was diluted, the experimental tubes were set up as follows:
1.0 µL experimental sample
18.5 µL nuclease free water
1.0 µL of forward primer
1.0 µL of reverse primer
0.5 µL of AMV reverse transcriptase
3.0 µL of Acces Quick™ Master Mix
25.0 µL Total

The experimental samples were prepared along with positive controls, Glyceraldehyde 3phosphate dehydrogenase (GAPDH) and beta actin. Amplification of the samples was
carried using the following parameters:
40 PCR cycles:
Denaturation: 94oC for 15 min
Annealing: 55-60oC for 1 min
Extension: 72oC for 30 sec
Final Extension: 72oC for 3 min
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RESULTS
Three RT-PCRs were performed on separate mRNA extractions. None of the
three reactions were positive for Nrp-1 mRNA in the neurosphere cell line (Figure 14).
There was also no amplification of GAPDH indicating an un-successful extraction of
mRNA. A second cell line, the T98 glioma cell line was also tested. The T98 cell line
was shown to contain both beta actin and GAPDH mRNA (Figure 14). Taken together,
the mRNA extraction protocol was effective but the reason behind the lack of mRNA
amplification from the neurosphere line remains to be answered.

Figure 14: Electrophoresis of PCR products. Lane assignments are as follows: (A)
Fisher ™ exACT Gene 1000 bp PCR DNA Ladder (B) Neurosphere, beta actin (C) T98
beta actin (D) Neurosphere GAPDH (E) T98 GAPDH (F) Neurosphere, Nrp-1 (G) T98,
Nrp-1, The T98 glioma cell line was positive for the controls, GAPDH and beta actin as
indicated by the appropriate banding in lanes C and E. The neurosphere cell line did not
display amplification of any of the PCR amplified sequences.

67

DISCUSSION
Sema3A was recently shown to be expressed nearly ubiquitously by GBMs. The
same cells were also shown to express the receptor Nrp-1 and migrate through autocrine
signaling (Bagci et al.). It seemed likely the SVZ isolated neurospheres would also
express Nrp-1. The results of the RT-PCR indicate the neurospheres do not transcribe
Nrp-1 mRNA as no amplification of the mRNA was achieved. Also discouraging was
the lack of GAPDH and beta actin amplification within the neurosphere lysates. This
would suggest a failed protocol, however, amplification in the control cell lines was
achieved. The lack of amplification is discouraging, and efforts to investigate the
findings have continued. Of note however, a lack of mRNA does not necessarily mean
Nrp-1 is not already expressed on the cells. In order to determine if Nrp-1 is in fact
present, a western blot needs to be performed. At the same time, a western blot should be
performed to determine if Sema3a is being released by the GBM cell lines. At this point
it seems unlikely the Sema3a – Nrp-1 interaction is the reason for the GBM induced
repulsion of neurospheres. Further studies will be needed to determine the factor(s)
responsible for the findings.
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CHAPTER SEVEN: EFFECT OF EXOSOMES ON NEUROSPHERE MIGRATION:

BACKGROUND
The role of exosomes in cancer progression has yet to be fully determined.
Exosomes play many roles in normal cellular physiology making it likely that exosomes
play multiple roles in cancer. Exosomes are known to contain cancer-specific mRNAs
that when taken into normal cells are translated and expressed (Baj-Krzyworzeka et al.).
The cancer specific mRNAs code for proteins important in cancer progression including
those necessary for cellular migration. The repulsive nature of GBM cells on
neurosphere migration has led to the hypothesis that exosomes may carry mRNA coding
for receptors to chemo-repellent ligands. To test, exosome-free GBM-conditioned media
was used in the transwell assay and compared to exosome containing media. The
comparison of exosome-free to exosome-containing media of the same origin would give
a generalized assessment of exosome involvement in neurosphere migration.

MATERIALS AND METHODS
EXOSOME FREE MEDIA
The creation of GBM-conditioned media was performed as described in chapter 4.
The conditioned media was centrifuged (Beckman – Coulter, Brea, CA.) for 10 minutes
at 300 x g to remove living cells. The supernatant was collected and centrifuged at 2000
x g for 20 minutes which pellets dead cells. To remove cellular debris the supernatant
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was centrifuged at 10000 x g for 30 minutes. Exosomes were pelleted by centrifuging at
100000 x g for 70 minutes twice. The centrifugation steps are thought to pellet the
exosomes without removing proteins found in the conditioned media. The exosome-free
conditioned-media was collected and subsequently used in the transwell assays as the
exosome free (-) sample. The procedure was used to create exosome-free media for the
U87MG, U138MG and T98G cell lines.
After analysis of the samples, exosome-free media was used in the transwell
assay. The GBM-conditioned media from the T98, U138 and U87 cell lines were split
into two groups, A and B. From group A the exosomes were removed creating an
exosome free sample. The splitting into two separate groups was essential in that each
group was derived from the same original sample. The migration induced by GBMconditioned media (B) was compared to the migration induced by the exosome-free
GBM-conditioned media (A) using an unpaired student’s t-test to determine statistical
significance.

SODIUM DODECYL SULFATE POLYACRYLAMIDE GEL ELECTROPHORESIS
(SDS-PAGE)
Ultracentrifugation at 110,000 x g is considered sufficient for the specific
separation of exosomes from conditioned media. To confirm, GBM-conditioned media
and exosome-free GBM-conditioned media assayed by SDS-PAGE. First, 1,000 mL of
1X NuPAGE SDS running buffer is prepared by combining 50 mL of 20X NuPAGE SDS
running buffer with 950 mL of dH2O. The 1X running buffer is separated into volumes
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of 800 mL and 200 mL. To the 200 mL sample, 500 μL of NuPAGE antioxidant is
added. The sample containing the antioxidant was added to the inner chamber, and the
other to the outer chamber. The gels were run at 250 V for 40 minutes (Bio-Rad,
Hercules, CA.), and visualized using Simply Blue Safestain (Invitrogen). (Figure 15).

PREPARATION OF FBS SAMPLES
Three experimental FBS samples were used during the experiments: un-modified
FBS, exosome-free FBS (-) and exosome-enriched FBS (+). The FBS (-) was produced
by centrifuging un-modified FBS at 110,000 x g for 24 hours. The end result of the
centrifugation step was an exosome-free supernatant and pellet of exosomes. The
supernatant was collected and used as the FBS (-) sample. The exosome pellet was resuspended in 1.0 mL of MEME and used as the FBS (+) sample. As with the exosomefree GBM-conditioned media, SDS-PAGE was performed to ensure the centrifugation
was exosome specific (Figure 16).

RESULTS
The specificity of the exosome removal process was tested using SDS-PAGE.
The procedure gave evidence to the presence or absence of bands between samples. The
GBM-conditioned media was tested first. Two cell lines were tested (T98 vs. T98
exosome-free and U87 vs. U87 exosome-free) for similarities and differences in protein
banding patterns. The SDS-PAGE does not give a protein quantification, but the results
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show similar banding patterns between the exosome-containing and exosome-free
samples (Figure 15). The finding indicates the ultracentrifugation step did not drastically
change protein levels found in the samples.
The FBS samples were also tested using SDS-PAGE. The banding patterns and
intensities were once again observed in each of the four FBS samples (un-modified FBS,
FBS (-), and FBS (+)). The gel indicates that each of the samples have similar banding
patterns but there is a large disparity in banding intensity (Figure 16). The strong protein
smears observed in the exosome-enriched samples coupled with the faint smears of the
exosome-free samples indicates the ultracentrifugation procedure may not have been
exosome specific.
After analysis of the samples, exosome-free media was used in the transwell
assay. The results of the study support our previous findings indicating a chemorepulsive effect of GBM-conditioned media on neurosphere migration (Figure 17). When
compared to the control group, each cell line (T98, U87 and U138) caused a significant
reduction in neurosphere migration. Interestingly, the data fails to show a reduction in
neurosphere migration when comparing the GBM-conditioned media to the exosome-free
GBM-conditioned media (Figure 17). The original hypothesis was that removal of
exosomes would cause a decrease in neurosphere migration. However, the transwell
assay did not show a decrease in migration. In fact, the T98 exosome-free media caused
an increase in migration as compared to the exosome-containing T98 media.
To test the validity of the preliminary findings, a second trial was performed. The
second assay tested the effect of exosome removal from GBM-conditioned media in the
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T98 and U87 cell lines. This time, the removal of exosomes caused a statistically
significant reduction in neurosphere migration in each cell line (Figure 18). Both the T98
and U87 cell lines showed a significant reduction in neurosphere migration when
exosomes were removed from the media. These findings support the initial hypothesis.
More trials are needed however to determine the actual effect of exosome removal.
The previous migration assays uncovered the intriguing chemo-repulsive effect of
FBS on neurosphere migration. Due to the similar chemo-repulsive nature observed
using GBM-conditioned media, it was hypothesized that exosomes found within the FBS
may play a similar role. The data from the FBS transwell assays indicate that all three
FBS samples caused a reduction in neurosphere migration compared to control (Figure
19). These findings support the previous chemo-repellent effect of FBS on neurosphere
migration. The main purpose for the experiment, however, was to investigate the effect
of exosome removal. The removal of exosomes from FBS caused no change in
neurosphere migration compared to un-modified FBS. This contradicts the initial
hypothesis, as it indicates exosome removal does not affect migration of neurospheres.
Interestingly however, a comparison of the FBS (+) and un-modified FBS samples saw a
significant change in migration. The exosome enriched sample caused an increase in
neurosphere migration as compared to the exosome free sample (Figure 19).
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Figure 15: SDS-PAGE performed on GBM-conditioned media in vitro. The samples
were run in duplicate. Lane assignments were as follows: (A,B) exosome free T98
supernatant (C,D) exosome free U87 supernatant (E,F) T98 supernatant (G,H) U87
supernatant. The procedure does not quantify protein levels, but does show similar
banding characteristics between the GBM-conditioned media and exosome free media for
both cell lines. This indicates that the exosome removal step was not removing soluble
proteins.
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Figure 16: SDS-PAGE performed on un-modified FBS samples to determine the
effectiveness of the exosome removal process. The samples are (A,B) un-modified FBS
(C,D) FBS (-) (E,F) exosome enriched (+) FBS pellet (G,H) FBS (+). The procedure
does not quantify protein levels but indicates the exosome removal procedure is only
marginally specific. The protein smears observed in the un-modified FBS samples are
much fainter in the FBS (-) samples. Conversely, the protein smears in the FBS (+)
samples appear much more concentrated than in the un-modified FBS samples. Together,
these findings indicate that the observed changes in neurosphere migration may be
exosome independent.
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Figure 17: Effect of exosome removal on neurosphere migration. The initial findings
indicated that neurosphere migration may be increased with exosome removal from
conditioned media as observed with the T98 and T98(-) groups.
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Figure 18: Effect of exosome removal on neurosphere migration. Tumor conditioned
media from the U87 and T98 cell lines were compared to exosome free GBMconditioned media of the same origin. In both cases, the overall neurosphere migration
was significantly reduced with exosome removal.
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Figure 19: Effect of un-modified, exosome free and exosome enriched FBS on
neurosphere migration. All three samples caused a statistically significant reduction in
neurosphere migration compared to the control sample. The FBS free sample did not
cause a change in migration as compared to the un-modified FBS; however, the FBS
enriched sample caused a significant increase in neurosphere migration compared to the
exosome free sample.

DISCUSSION
The purpose of the study was to determine if exosomes play a role in neurosphere
migration. To obtain exosomes, samples were spun at 110,000 x g. The high speed
centrifugation was thought to be sufficient for the separation of exosomes from solution.
Furthermore, the spin was thought specific to the isolation of exosomes meaning that
exosomes would be the only factor removed from the conditioned media. To test,
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exosome-free samples were compared to un-modified samples of the same origin using
SDS-PAGE.
The first samples analyzed were GBM-conditioned media from the T98, U87 and
U138 cell lines. The protein banding varied between cell lines but was similar in samples
taken from the same cell type, including a comparison of exosome-free and un-modified
samples. It should be noted that SDS-PAGE does not quantify or positively identify
proteins in a sample but it can be used to make general observations as to changes in
banding intensities between samples such as between exosome-containing and exosomefree media. The samples tested using SDS-PAGE were also used in the initial transwell
assay. Only the T98 cell line showed any change in overall neurosphere migration.
Surprisingly, the removal of exosomes from the T98 conditioned media did not cause an
overall reduction in migration, but rather a net increase. A second trial was run using the
same cell lines to verify the initial findings. Results of the second trial did not support
the initial findings. This time the T98 and U87 cell lines saw a reduction in neurosphere
migration when exosomes were removed.
At the same time the GBM-conditioned media was tested, a parallel study was
conducted using FBS samples. As previously discussed, the FBS samples included unmodified FBS, exosome-free FBS and exosome-enriched FBS. Just as in the GBMconditioned media study, protein levels were observed using SDS-PAGE. The gel shown
in figure 16 indicates the exosome removal process may not be exosome specific. The
un-modified FBS sample contains prominent protein smears, while the exosome-free
sample is nearly devoid of banding. This observation can be quickly associated with a
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poor exosome removal process. However, the protein smears could be due to the
presence of exosome bound proteins. The centrifugation steps would increase the
exosome density and the protein banding could be interpreted instead as an indicator of
exosome presence. Regardless, the findings from the SDS-PAGE illuminate the need for
a more conclusive test to be performed to identify the presence or absence of exosomes.
Therefore, findings from this study cannot be conclusively correlated to the presence or
absence of exosomes. However, the series of migration assays performed do appear to be
influenced by the removal or enrichment with GBM derived exosomes. It is the opinion
of the author that future exosome studies will support the initial findings reported in this
study, and definitively link exosomes to a change in cellular motility.
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CHAPTER 8: SYNOPSIS AND CONCLUSIONS

BACKGROUND
The basis of this project was built upon five initial hypotheses; 1) Neurospheres
could be isolated from the subventricular zone (SVZ) of the adult mouse brain; 2)
Neurospheres would display directed migratory capabilities when separated from
chemo-attractants; 3) Neurospheres would preferentially migrate towards
glioblastoma cell lines; 4) Migration would be due in large part to CXCR4 receptor
interaction with GBM-released SDF-1α and would be independent of the physical
presence of the GBM cells: 5) Motility would be reduced when exosomes were
removed from tumor-conditioned media. These hypotheses were tested and several
conclusions could be drawn.

RESULTS

ISOLATION, PROLIFERATION AND DIFFERENTIATION OF MURINE NEURAL
STEM CELLS:

The initial hope was to isolate cells from the SVZ of the adult mouse brain. This
was achieved and the isolates were maintained using the neurosphere culturing technique.
The neurospheres were cultured to passage 27 and were able to continuously re-populate
the flask, a clear stem-cell indicator. A positive confirmation of stem cells also includes
testing the differentiation capabilities of the isolates. Neural stem cells should have the
ability to differentiate into oligodendrocytes, astrocytes and neurons. Because of issues
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discussed previously, the SVZ isolates were only differentiated into oligodendrocytes as
confirmed through a positive identification of the oligodendrocyte marker O4. A lack of
positive markings for neurons and astrocytes means the isolates could not be positively
identified as neural stem cells. Although the cells were able to form neurospheres for 25
passages, a quality possessed by stem cells, lack of complete differentiation did not allow
for complete confirmation of stem cells.

STROMAL DERIVED FACTOR 1α (SDF-1α) AND FETAL BOVINE SERUM (FBS)
INDUCED MIGRATION OF SVZ DERIVED NEUROSPHERES:
In order to determine the effect of GBMs on neurosphere motility, the
neurospheres needed to be capable of inducible migration. To test, neurospheres were
separated from known chemo-attractant SDF-1α. Exogenous, incremental additions of
SDF-1α to un-modified media allowed for a measurement of motility in a model of
escalating concentrations. The neurospheres responded to the addition of exogenous
SDF-1α, albeit in a dose-dependent manner. SDF-1α concentrations between 50 and 100
mg/mL acted as statistically significant chemo-attractants. The 200 mg/mL SDF-1α
samples caused the opposite to occur, a net decrease in neurosphere migration. This
confirms the findings of other groups, in that high SDF-1α may also act as a chemorepellent when found at high concentrations. Surprisingly, SDF-1α levels as high as 25
mg/mL had no effect on migration. This indicates an SDF-1α concentration dependence
in the governance of neurosphere migration.

82

A lack of information from the literature led to the investigation of the influence
of FBS on neurosphere migration. FBS had previously been shown to induce the
migration of the GBM cell lines used within the study. The same effect was expected to
occur with the use of the SVZ isolated neurospheres. Again, the neurospheres acted
opposite to the expectations as overall migration was significantly reduced when exposed
to FBS. The repulsive effect of the FBS is both intriguing and novel and identifies an
area that needs future studies to elucidate the mechanism(s).

THE INFLUENCE OF GBM CELL LINES ON THE MIGRATION OF
NEUROSPHERES:
The SVZ isolated neurospheres were induced to migrate using exogenous
additions of SDF-1α. Doing so indicated the net movement of the neurospheres could be
influenced by external stimuli. Since the addition of SDF-1α was sufficient to induce
migration, it was hypothesized the addition of nutrient deprived GBM cells would cause a
similar response. The GBM nutrient deprivation was performed to induce the release of
tumor derived SDF-1α. The results of the transwell migration assays indicate that
nutrient deprivation of GBM cell lines is not sufficient to cause an increase in
neurosphere migration. Furthermore, GBM cell lines consistently caused an overall
decrease in neurosphere migration through the release of soluble factors. Within the
context of the project, GBM cell lines appear to act as a chemo-repellent to SVZ isolated
neurospheres. These findings are very surprising in that other labs have indicated GBMs
act as strong chemo-attractant to neural stem cells. A plausible cause for the findings
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could be a disconnect between the protein-protein interactions of murine neurosphere
receptors and human derived brain tumors. The highly conserved nature of the proteins
between species leaves this hypothesis in doubt however. To truly test, a complete
proteomic screen should be performed on the receptors found on the neurospheres as well
as the tumor-derived proteins within the conditioned media.

SDF-1α CONCENTRATIONS IN HYPOXIA INDUCED GBM CELL LINES:
The concentration dependent, SDF-1α induced migration coupled with the
chemo-repulsive nature of the GBM cell lines led to an investigation of the GBM derived
SDF-1α concentrations. As expected, the 50 mg/mL concentration threshold of
exogenous SDF-1α was found to be greater than the concentrations released by the GBM
cell lines. A comprehensive literature review indicated limited information on normal
concentrations of SDF-1α. The study performed here was novel in that it determined
SDF-1α concentrations for the U138, T98 and SF767 GBM cell lines.
The validity of the first sandwich ELISA was tested by performing a second trial.
Each of the four cell lines tested were found to release SDF-1α into the conditioned
media. The concentrations varied less between cell lines and it is the opinion of the
investigator that the second trial yielded more accurate results mainly because the
samples were not initially diluted. The efficacy of the nutrient deprivation on SDF-1α
release was also tested. The results show that as the duration of the nutrient deprivation
increased, so did the release of SDF-1α. Statistical analysis could not be performed since
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only one ELISA was performed for each time point. Future ELISAs will be performed
and are expected to show the increase to be statistically significant.

NEUROSPHERE PRODUCTION OF NEUROPILIN-1:
Once the attraction of neurospheres to GBM cell lines was shown to be incorrect,
we began initial investigations into elucidating the mechanism behind the findings. The
sandwich ELISA experiments demonstrated that GBM-released SDF-1α levels were
below the threshold concentrations determined during the exogenous additions necessary
to induce migration. The first thought was to check the neurospheres for the expression
of CXCR4, the receptor to SDF-1α. A hypothesized low level expression of CXCR4
would help explain the lack of chemo-attraction to the GBM cell lines, but would not
address the chemo-repulsive effects observed. The investigation turned instead to GBMreleased chemo-repellents. A semaphorin family member, Sema3A became the likely
answer to the search as it has shown to be nearly ubiquitously released by GBMs. The
RT-PCR was performed to test for the presence of Nrp-1 mRNA. None of the samples
displayed an amplification of the mRNA target however. While the lack of mRNA
decreases the likelihood of protein expression it cannot be ruled out. A western blot
assay would definitively determine whether or not Nrp-1 is present on the neurospheres.

85

ROLE OF EXOSOMES IN NEUROSPHERE MIGRATION:
The results of the exosome-free transwell assays were quite interesting. The issue
with the study however, was with the exosome removal process. As mentioned
previously, SDS-PAGE was performed on the exosome-free and exosome-containing
media samples of the same origin. The image shown in figure 16, the end result of the
SDS-PAGE, illustrates striking differences in banding intensities. The differences in
protein banding can be interpreted in two ways. The changes in banding intensity could
indicate the exosome removal process was also removing soluble proteins. This scenario
could cause changes in migration rates due to the presence or absence of soluble proteins,
thus making a definitive link to exosomes impossible. However, the SDS-PAGE results
could also be interpreted in a positive light as well. The theultracentrifugation was used
to specifically isoloate, and condense exosomes into a dense pellet. The exosome pellet
would be rich in membrane bound proteins. Because of this, one may expect to see a
difference in protein banding and in turn the differences in protein intensities could be
interpreted as a positive identification of exosome presence. Regardless of which
explanation is correct, it is believed that a more definitive exosome removal process is
needed for further studies. It is the opinion of the author that such a process would yield
similar findings and support the hypothesized chemo-attractive nature of exosomes based
on the contents within exosomes as indicated in the literature.
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CONCLUSIONS:


Cells capable of continual self-renewal were successfully isolated from the SVZ
of the mouse brain and subsequently cultured as neurospheres through passage 25.



Both SDF-1α and FBS were able to induce neurosphere migration. The SDF-1α
acted as a chemo-attractant in a concentration dependant manner, however, FBS
acted unexpectedly as a chemo-repellent.



Murine neurospheres isolated from the SVZ do not migrate preferentially towards
GBM cell lines. The data indicates that neurospheres are repulsed by GBM cells.
This suggests that glioblastoma cell lines excrete chemo-repellents which act to
“outcompete” the attractants.



Neurosphere repulsion is tumor-conditioned media dependent since removal of
the GBM cells did not cause a change in the Neurosphere motility.



Quantification of SDF-1α from tumor-conditioned media using Sandwich-ELISA
indicated levels far below the concentrations needed exogenously to induce
neurosphere migration.



Neuropilin-1 mRNA was not found in the neurosphere lysate.



Preliminary data indicates that exosomes influence migration rates of SVZ
isolated neurospheres. The SDS-PAGE assay clearly indicates a need for an
adjustment in the exosome isolation procedure for use in future studies.
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